International Journal of Pharma and Bio Sciences
    ISSN 0975-6299

Int J Pharm Bio Sci Volume 14 Issue 4, October - December, Pages:26-37

Realm of Pathological Lesions of Breast in A Tertiary Care Teaching Hospital in A Dominantly Tribal Region

KirtiPardeshi, Hoogar M.B, Satish Bhasale and Saniya Dsouza

The breast, an important organ of lactation in mammals, is one of the most common organs affected by various physiological and pathological processes. The pathological processes that affect the breast can be non-neoplastic and neoplastic lesions. The non-neoplastic lesions include aberrant development of breast infectious and inflammatory lesions. Neoplastic lesions of the breast comprise benign and malignant tumours of the breast. The present retrospective study aims to study the spectrum of lesions in pathological breast lesions. We have studied various non-neoplastic and neoplastic lesion of the breast and their clinic pathological correlation wherever possible and so also to know the incidence of various malignant lesions of the breast in a tertiary care teaching hospital. The study is conducted in the Department of Pathology, Vedantaa Institute of Medical Sciences, Palghar, Maharashtra, a predominantly tribal region, from January 2022 to April 2023. All excision and incision biopsy specimens and mastectomy specimens are included in the study. After the specimens were processed by standard tissue processing procedures of formal fixation and paraffin embedding protocol, standard paraffin sections were cut and stained with routine histopathological stain. In the results, 86 specimens from breast lesions were received, of which 91.8 % are neoplastic and 8.1 % are non-neoplastic lesions. Among neoplastic lesions, 69.7 % constituted benign lesions, commonly observed in the age group of 31-40 years, and 6.9 % are malignant lesions commonly noted in the age group of 61-70. In conclusion, it is observed that Fibroadenoma is the most common benign tumour, and Infiltrating duct carcinoma (NOS) is the most common tumour among the malignant breast. Among the special types of invasive breast carcinomas, metaplastic carcinoma of the breast with an increased incidence is an unforeseen finding of the present study.

Keywords: Neoplastic and non-neoplastic lesions, Breast lesions, invasive duct carcinoma, metaplastic carcinoma of the breast, fibro adenoma, squamous differentiation, ulcero-proliferative lesion of the breast.
Full HTML:


  1. Dabbs DJ. Breast pathology. Amsterdam: Elsevier Saunders; 2012.
  2. Dr. Bhavani DC, Dr. Neeraja DM, Dr. Sravani DP. A study of histopathological spectrum of breast lesions in a tertiary care hospital. Int J ClinDiagnPathol. 2019;2(2):356-60. doi: 10.33545/pathol.2019.v2.i2f.128.
  3. Kalyani S, MehrajBanu OA. Study of Breast lesions in the tertiary health care center. Int J Recent Trends Sci Technol. 2016;18(3):415-9.
  4. Dr. Maurya G, Dr. Singh SK, Dr. Pandey Pinki, Dr. Rashmi, this is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  5. Nwafor CC, Udo IA. Histological characteristics of breast lesions in Uyo, Nigeria. Niger J Surg. 2018;24(2):76-81. doi: 10.4103/njs.NJS_29_17, PMID 30283216.
  6. Dhruw D, Chiklikar K. A study of patterns of breast lesions in the tertiary care centre of Bastar region IOSR journal of dental and medical sciences (IOSR-JDMS) e-ISSN: 2279-0853. p-ISSN: 2279-0861. Vol. 17(7). Ver 4 (July. 2018). P. 10-4.
  7. Yerakly F, Tadele AK. Histopathologic patterns of breast lesions in Hawassa University comprehensive specialized hospital, Sidama region, Ethiopia. A six-year retrospective study (September 2015 G.C to August 2020 G.C.). ClinOncol. 2022;7:1895. ISSN: 2474-1663.
  8. Yogalakshmi and Kavitha: histopathological spectrum of breast lesions. Int J Sci Study | April 2019 |;7 | Issue 1.
  9. Padmom L, Sapru K, Beena D. Histopathological Spectrum of Breast Lesions – A Study Done in a Tertiary Care Hospital. J Evol Med Dent Sci. 2020;9(17):1412-5. doi: 10.14260/jemds/2020/308.
  10. RanjitsinghSulhyan K, RameshraoAnvikar A, MahamadisakMujawar I, Tiwari H. Histopathological study of breast lesions. Int J Res Rev. 2017Jan.31 [cited 2023May9];5(1):32-1.
  11. Abed WT, Mousa SA. Detection of anti-rubella IgM, IgG and Antisperm Antibodies in the Sera of Aborted and Non-Pregnant Women in the Kirkuk City. Indian J Forensic Med Toxicol;13(4). doi: 10.5958/0973-9130.2019.00516.4.
  12. Sree ND et al. Int J Res Med Sci. 2018 October;6(10):3397-402.
  13. Mrudula, et al. Histopathological spectrum of breast lesions. Asian J Med Sci | Feb 2023 |;14 | Issue 2.
  14. Dnyaneshwar JS, Kale PB, Giri A, Valand AGA. Histopathological study of Neoplastic and Non Neoplastic Breast lesions at a Rural tertiary care centre in India. Indian J Pathol Res Pract. 2017;6(2):387-92.
  15. Takkallapelli M, Boda J, Shaik M, Praneetha N. Neoplastic & Non neoplastic histopathological study of breast lesions. Eur J MolClin Med ISSN 2515-8260. 2022;09(07).
  16. Kumbhakar D, Talukdar PP. Histopathological patterns of breast lesions - a hospital-based study. J Evid Based Med Healthc. 2021;8(10):567-74. doi: 10.18410/jebmh/2021/111.
  17. Sangma MB, Panda K, Dasiah S. A clinico-pathological study on benign breast diseases. J ClinDiagn Res. 2013 March;7(3):503-6. doi: 10.7860/JCDR/2013/5355.2807, PMID 23634406.
  18. Takalkar UV, Asegaonkar SB, Kulkarni U, Saraf M, AdvaniSUnmeshVidyadharTakalkar et al. Clinicopathological Profile of Breast Cancer Patients at a Tertiary Care Hospital in Marathwada Region of Westen India. Asian Pac J Cancer Prev. 2016;17(4):2195-8. doi: 10.7314/apjcp.2016.17.4.2195, PMID 27221917.
  19. Makki J. Diversity of Breast Carcinoma: Histological Subtypes and Clinical Relevance. Clin Med Insights Pathol. 2015;8:23-31. doi: 10.4137/CPath.S31563. PMID 26740749.
  20. Sandhu, et al. Profi le of breast cancer patients(3, July-September); 2019. International Journal of Science and Healthcare Research. Available from: 16Vol.4 [cited 23/8/2023].
[Download PDF]
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy
Pharmaceutical Fields
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmaceutics
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Novel drug delivery system
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Nanotechnology
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmacology
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmacognosy
© Copyright 2009-2015 IJPBS, India. All rights reserved. Specialized online journals by ubijournal. Website by Ubitech Solutions
         Home I Contact I Terms & Conditions